Can Anti-VEGF Therapy Benefit Rare Retinal Diseases?
Several case studies and series have offered some evidence for use
Can Nanotechnology Improve Treatment of Retinal Disease?
Very small particles could mean very big changes for retina
Coding Q&A
Posterior Segment Intraocular Foreign Body Removal
Controversies in Care
Fundus Autofluorescence Imaging: Illuminating Valuable Information?
Focus On
Pattern laser offers homogenous success
Journal Club
New and noteworthy studies
Special Section Sponsored By Optos
Expanding Horizons in Retinal Imaging
Subspecialty News
Eylea maintains VA gains at 96 weeks; Rising Medicare costs for wet AMD; Microvascular changes predict disability; and more
Taking the EMR Plunge
Live — and learn — vicariously as one retinal practice undertakes EMR implementation
The Pros & Cons of Conducting Clinical Trials in a Private Practice
Opportunities to innovate are at hand, but not without hard work and risk
Understanding the Role of Bruch's Membrane in CNV
The more we know about retinal structure, the better our chances of treating disease
Update on Clinical Genetic Testing for AMD
Several genetic screenings are now available to determine patients' risks
Upfront: From the Editor-in-Chief
Time to "think different" about EMR
Visual Perception for the Blind: The BrainPort Vision Device
By using their tongues, sightless people may be able to "see" again
By using their tongues, sightless
Wrapping up a Year in Retina
A final sampling from our 2011 annual meeting offers guidance on imaging, surgical technique and the status of several investigational therapies